Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF MRNA

  • Read more about METHOD OF ELIMINATING INHIBITORY/INSTABILITY REGIONS OF MRNA
US Patent 5,965,726
Filed on 1997-05-02

HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS

  • Read more about HUMAN PROSTATIC CELL LINES IMMORTALIZED BY ADENOVIRUS 12-SIMIAN VIRUS 40 (AD12/SV40) HYBRID VIRUS
US Patent 5,716,830
Filed on 1997-02-25

CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES

  • Read more about CONFORMATIONALLY LOCKED NUCLEOSIDE ANALOGUES
US Patent 5,869,666
Filed on 1997-03-14

ETS1-GENE: A HUMAN TUMOR SUPPRESSOR GENE

  • Read more about ETS1-GENE: A HUMAN TUMOR SUPPRESSOR GENE
US Patent 5,795,866
Filed on 1997-05-12

HUMAN CORNEAL EPITHELIAL CELL LINES WITH EXTENDED LIFESPAN

  • Read more about HUMAN CORNEAL EPITHELIAL CELL LINES WITH EXTENDED LIFESPAN
US Patent 5,786,201
Filed on 1995-06-07

HUMAN CORNEAL EPITHELIAL CELL LINES WITH EXTENDED LIFESPAN

  • Read more about HUMAN CORNEAL EPITHELIAL CELL LINES WITH EXTENDED LIFESPAN
US Patent 5,585,265
Filed on 1994-06-03

HETEROLOGOUS BOOSTING IMMUNIZATIONS FOR THE GENERATION OF CTL AND ANTITUMOR RESPONSES

  • Read more about HETEROLOGOUS BOOSTING IMMUNIZATIONS FOR THE GENERATION OF CTL AND ANTITUMOR RESPONSES
Patent Cooperation Treaty
PCT/US1997/006632
Filed on 1997-04-21

BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE

  • Read more about BASAL CELL CARCINOMA TUMOR SUPPRESSOR GENE
US Patent 6,552,181
Filed on 1997-05-16

Biopolymer-Bound Nitric Oxide-Releasing Compositions, Incorporating Same and Methods of Treating Biological Disorders Using Same

  • Read more about Biopolymer-Bound Nitric Oxide-Releasing Compositions, Incorporating Same and Methods of Treating Biological Disorders Using Same
US Patent 6,200,558
Filed on 1997-04-22

USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS

  • Read more about USE OF NITRIC OXIDE RELEASING COMPOUNDS AS HYPOXIC CELL RADIATION SENSITIZERS
US Patent 5,837,736
Filed on 1997-03-11

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1545
  • Page 1546
  • Page 1547
  • Page 1548
  • Page 1549
  • Page 1550
  • Page 1551
  • Page 1552
  • Page 1553
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health